US · Healthcare

Spencer Pharmaceutical Inc (SPPH)

Biotechnology

Spencer Pharmaceutical Inc (SPPH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SPPH

P/E ratio

25.00

Spencer Pharmaceutical Inc (SPPH) — FAQ

What is SPPH's P/E ratio?

The price-to-earnings (P/E) ratio for Spencer Pharmaceutical Inc (SPPH) is 25.00 (data as of 2026-05-23).

Does Spencer Pharmaceutical Inc pay a dividend?

Dividend yield is not available in the current snapshot for Spencer Pharmaceutical Inc (SPPH). Check the MyAverix Finance app for the latest dividend data.

What sector is Spencer Pharmaceutical Inc in?

Spencer Pharmaceutical Inc (SPPH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SPPH listed on?

SPPH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)